Infectious Diseases

502 soru

Soru 281Soru →

Match each clinical presentation of a genital ulcer disease with its most appropriate first-line pharmacotherapy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 24-year-old man presents with a single, painless, indurated penile ulcer with a clean base and non-tender bilateral inguinal lymphadenopathy.
A 21-year-old man presents with multiple painful, deep genital ulcers with a purulent base and tender, unilateral, fluctuant inguinal lymph nodes.
A 28-year-old man presents with painful, unilateral inguinal lymphadenopathy with a 'groove sign'. He reports having a small painless genital ulcer a few weeks ago that healed spontaneously.
A 26-year-old woman presents with multiple small, grouped, severely painful vesicles and shallow ulcers on an erythematous base on her labia.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align primary syphilis with penicillin, chancroid with azithromycin or ceftriaxone, lymphogranuloma venereum with an extended course of doxycycline, and genital herpes with oral valacyclovir.
Each genital ulcer disease has a distinct clinical phenotype that guides targeted pharmacotherapy. Primary syphilis presents with a painless chancre and is treated with penicillin. Chancroid presents with painful, purulent ulcers and is treated with azithromycin or ceftriaxone. Lymphogranuloma venereum presents with a transient painless ulcer followed by painful buboes and requires 21 days of doxycycline. Genital herpes presents with grouped painful vesicles and is treated with oral antivirals.

Adım Adım Çözüm

1
Analyze the characteristics of the genital ulcer (painful vs. painless, single vs. multiple, clean vs. purulent base) and the associated lymphadenopathy.
Identified the likely pathogens: Treponema pallidum (painless), Haemophilus ducreyi (painful, purulent), Chlamydia trachomatis L1-L3 (transient painless ulcer with severe late adenopathy), and Herpes Simplex Virus (painful vesicles).
Genital ulcer diseases have distinct clinical phenotypes that often allow for a highly accurate presumptive clinical diagnosis.
2
Select the appropriate guideline-directed antimicrobial therapy for each identified pathogen.
Matched T. pallidum with penicillin, H. ducreyi with azithromycin/ceftriaxone, C. trachomatis with doxycycline, and HSV with valacyclovir.
Targeted antimicrobial therapy is essential for curative treatment, symptom resolution, and prevention of transmission.

Anahtar Kavram

Diagnosis and management of genital ulcer diseases based on clinical presentation
Soru 282Soru →

Match each clinical presentation of infective endocarditis with the most appropriate targeted diagnostic evaluation or therapeutic intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 68-year-old patient is diagnosed with native valve endocarditis. Blood cultures yield a non-enterococcal Group D Streptococcus (Streptococcus gallolyticus).
A 52-year-old patient with a mechanical mitral valve placed three years ago presents with acute endocarditis. Blood cultures rapidly grow methicillin-susceptible Staphylococcus aureus.
A 74-year-old patient develops subacute endocarditis following a cystoscopy. Blood cultures grow Enterococcus faecalis demonstrating high-level aminoglycoside resistance.
A 45-year-old patient experiencing homelessness presents with severe body louse infestation and culture-negative endocarditis.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Streptococcus gallolyticus pairs with performing a screening colonoscopy. Staphylococcus aureus prosthetic valve endocarditis pairs with nafcillin, rifampin, and gentamicin. Enterococcus faecalis with high-level aminoglycoside resistance pairs with ampicillin and ceftriaxone. Culture-negative endocarditis in a patient with a body louse infestation pairs with obtaining serology for Bartonella quintana.
Each pairing correctly applies current clinical guidelines for infective endocarditis: S. gallolyticus requires colonoscopy due to a high rate of concomitant colon cancer. S. aureus on a prosthetic valve necessitates a three-drug regimen including rifampin for biofilm penetration. HLAR E. faecalis requires ampicillin plus ceftriaxone for dual beta-lactam synergy. B. quintana is the primary suspect in louse-associated culture-negative endocarditis, requiring serological confirmation.

Adım Adım Çözüm

1
Identify the underlying pathogen and host risk factors in each clinical vignette.
Pathogens identified are S. gallolyticus, S. aureus (prosthetic valve), E. faecalis (with HLAR), and a culture-negative organism associated with body lice.
Management of infective endocarditis is highly tailored to the specific organism, its resistance profile, and whether native or prosthetic material is involved.
2
Determine the unique complication, diagnostic requirement, or therapeutic adjustment for each pathogen.
S. gallolyticus requires GI workup. Prosthetic S. aureus requires biofilm penetration. HLAR Enterococcus requires non-aminoglycoside synergy. Louse-borne culture-negative endocarditis points to Bartonella.
Standard endocarditis protocols fail if these specific nuances (e.g., biofilms, HLAR, occult malignancy) are not addressed.
3
Match the specific pathogen requirements to the listed interventions.
The pairings logically align the microbiologic and epidemiologic clues with the standard-of-care guidelines.
This confirms mastery of pathogen-specific management pathways in infectious diseases.

Anahtar Kavram

Targeted diagnostic and therapeutic management of infective endocarditis based on organism identity, resistance patterns, and host risk factors.
Soru 283Soru →

A 62-year-old man is evaluated in the hospital on hospital day 3. He was initially admitted for high fever and rigors. His past medical history is significant for end-stage renal disease requiring hemodialysis via a right internal jugular tunneled catheter. Upon admission, peripheral and catheter-drawn blood cultures were obtained, and he was started on empiric antimicrobial therapy with intravenous vancomycin and piperacillin-tazobactam. Today, his temperature is 37.2°C (99.0°F), blood pressure is 128/76 mmHg, and heart rate is 82/min. The admission blood cultures are now positive for Staphylococcus aureus in 4 out of 4 bottles. Susceptibility testing reveals the isolate is resistant to penicillin, but susceptible to oxacillin, cefazolin, and vancomycin. A review of the patient's medical record indicates a documented allergy to amoxicillin, which the patient describes as a 'flat, red skin rash' that occurred several days into a treatment course 10 years ago, without associated pruritus, facial swelling, or difficulty breathing. Which of the following is the most appropriate modification to his current pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Transition to intravenous cefazolin monotherapy

Cevap

Transition to intravenous cefazolin monotherapy.
The patient has Methicillin-Susceptible Staphylococcus aureus (MSSA) bacteremia, as evidenced by the susceptibility to oxacillin. The standard of care for MSSA endovascular infections and bacteremia dictates the use of a narrow-spectrum beta-lactam, such as an anti-staphylococcal penicillin (nafcillin, oxacillin) or a first-generation cephalosporin (cefazolin). These agents are definitively superior to vancomycin, providing faster bacterial clearance, lower rates of relapse, and reduced mortality. The patient's reported amoxicillin allergy—a delayed, flat, non-itchy rash—is characteristic of a non-IgE mediated (Type IV) mild hypersensitivity or a viral-antibiotic interaction, not true anaphylaxis. Furthermore, cefazolin has a unique R1 side chain that does not cross-react with other penicillins or cephalosporins. Therefore, it is entirely safe and represents the optimal stewardship choice for definitive therapy.

Adım Adım Çözüm

1
Interpret the blood culture and susceptibility results.
The pathogen is Staphylococcus aureus that is susceptible to oxacillin, confirming it is Methicillin-Susceptible Staphylococcus aureus (MSSA).
Accurate pathogen identification and resistance profiling dictate the definitive antimicrobial choice.
2
Determine the optimal class of antibiotics for MSSA bacteremia.
Anti-staphylococcal penicillins (e.g., nafcillin, oxacillin) or first-generation cephalosporins (e.g., cefazolin) are the superior agents.
Clinical data consistently demonstrate that beta-lactams yield faster clearance and lower mortality rates for MSSA bacteremia compared to vancomycin.
3
Evaluate the patient's reported penicillin allergy and assess cross-reactivity risk.
The patient describes a delayed, non-pruritic maculopapular rash, which is a mild, non-IgE mediated reaction. Cefazolin has a distinct R1 side chain and negligible cross-reactivity with penicillins.
Understanding allergy phenotypes prevents unnecessary avoidance of first-line therapies. A mild delayed rash is not a contraindication to cefazolin.

Anahtar Kavram

For Methicillin-Susceptible Staphylococcus aureus (MSSA) bacteremia, narrow-spectrum beta-lactams (like cefazolin or nafcillin) are superior to vancomycin. A history of a mild, non-IgE mediated delayed rash to penicillin is not a contraindication to cefazolin therapy.
Soru 284Soru →

A 3434-year-old woman presents to the clinic for evaluation of a skin rash. She noticed the rash on her right posterior thigh 44 days ago, and it has steadily increased in size. She recently returned from a camping trip in Maine. The patient reports mild fatigue and muscle aches but denies fever, joint swelling, or shortness of breath. Her temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 120/78 mm Hg120/78\text{ mm Hg}, and pulse is 76/min76\text{/min}. Physical examination reveals a 10-cm10\text{-cm}, annular, erythematous plaque with a central area of clearing on the right posterior thigh. The remainder of the examination is unremarkable. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Prescribe oral doxycycline

Cevap

Prescribe oral doxycycline
The correct action is to prescribe oral doxycycline. This patient presents with a classic erythema migrans rash (annular, erythematous plaque with central clearing) and a history of recent travel to a Lyme-endemic area, which is diagnostic for early localized Lyme disease. In early localized disease, empiric treatment with an oral antibiotic (such as doxycycline, amoxicillin, or cefuroxime) should be initiated immediately based entirely on clinical findings.

Adım Adım Çözüm

1
Identify the primary clinical finding and its significance.
The patient has a large, expanding annular erythematous plaque with central clearing (erythema migrans) after visiting a Lyme-endemic area.
Erythema migrans is the hallmark physical finding of early localized Lyme disease.
2
Determine the appropriate diagnostic approach.
Diagnosis is made clinically based on the characteristic rash; serologic testing is unnecessary at this stage.
Antibodies to Borrelia burgdorferi often take weeks to develop, so serology has low sensitivity early in the disease course and can yield false-negative results.
3
Select the optimal management strategy.
Initiate empiric oral antibiotic therapy.
Oral doxycycline is the first-line treatment for early localized Lyme disease in non-pregnant adults.

Anahtar Kavram

Diagnosis and management of early localized Lyme disease
Soru 285Soru →

A 54-year-old man is evaluated in the intensive care unit for a new-onset fever. He was admitted 6 days ago following a severe motor vehicle collision that resulted in multiple rib fractures and a pulmonary contusion. He required endotracheal intubation and mechanical ventilation on the day of admission. Over the past 24 hours, he has developed a temperature of 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}) and requires an increasing fraction of inspired oxygen (FiO2\text{FiO}_2) and positive end-expiratory pressure. Endotracheal suctioning yields thick, purulent secretions. A chest radiograph reveals a new right lower lobe consolidation. His leukocyte count is 16,500/mm316,500/\text{mm}^3. A bronchoalveolar lavage is performed, and he is started on empiric intravenous vancomycin and cefepime. Two days later, his oxygenation has stabilized. The bronchoalveolar lavage fluid cultures grow >104 CFU/mL> 10^4 \text{ CFU/mL} of *Pseudomonas aeruginosa*. The isolate is susceptible to cefepime, piperacillin-tazobactam, and meropenem. No other organisms are isolated. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Discontinue vancomycin and continue intravenous cefepime

Cevap

Discontinue vancomycin and continue intravenous cefepime.
The correct response demonstrates appropriate antibiotic stewardship by de-escalating empiric broad-spectrum therapy once culture data are available. The patient has ventilator-associated pneumonia (VAP) and was started on empiric vancomycin (for MRSA) and cefepime (for Pseudomonas and other Gram-negatives). Bronchoalveolar lavage cultures definitively isolated *Pseudomonas aeruginosa* susceptible to cefepime, without any growth of MRSA. Therefore, vancomycin should be discontinued to reduce the risk of adverse effects (e.g., acute kidney injury), and cefepime should be continued as targeted, single-agent therapy.

Adım Adım Çözüm

1
Evaluate the clinical presentation and initial management.
The patient developed ventilator-associated pneumonia (VAP) and was appropriately started on empiric broad-spectrum coverage for MRSA (vancomycin) and antipseudomonal beta-lactam (cefepime).
Empiric VAP therapy must cover the most common, high-risk nosocomial pathogens based on local antibiograms and patient risk factors.
2
Analyze the culture and susceptibility data.
Cultures grew only *Pseudomonas aeruginosa*, which is fully susceptible to the currently administered cefepime. Notably, no MRSA or other Gram-positive pathogens were isolated.
Definitive antibiotic therapy relies on pathogen identification and susceptibility testing to optimize efficacy and minimize collateral damage.
3
Apply the principles of antibiotic stewardship to modify therapy.
Vancomycin should be discontinued to eliminate unnecessary MRSA coverage, and cefepime can be continued as targeted monotherapy.
De-escalation of empiric broad-spectrum antibiotics to narrower, targeted agents prevents the development of multidrug-resistant organisms and reduces medication-related adverse effects (such as vancomycin-induced acute kidney injury).

Anahtar Kavram

In the management of ventilator-associated pneumonia (VAP), empiric broad-spectrum antibiotics should be de-escalated to targeted monotherapy as soon as culture and susceptibility results are available and demonstrate a susceptible pathogen.
Soru 286Soru →

An 81-year-old female resident of a skilled nursing facility is currently recovering in the intensive care unit after presenting three days prior with severe distributive shock secondary to a catheter-associated urinary tract infection. On admission, she was hypotensive and tachycardic, and empiric antimicrobial therapy was initiated with intravenous vancomycin and piperacillin-tazobactam. Today, she is hemodynamically stable, off vasopressor support, and her temperature has normalized to 37.1°C (98.8°F). The indwelling urinary catheter was removed on the first day. Both the admission urine and blood cultures have grown *Escherichia coli*. The susceptibility report for the bloodstream isolate is provided below:

Antimicrobial AgentSusceptibility
AmpicillinResistant
CeftriaxoneResistant
CefepimeResistant
Piperacillin-tazobactamSusceptible
GentamicinSusceptible
MeropenemSusceptible

Based on the culture results and the patient's current clinical status, which of the following is the most appropriate definitive pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Monotherapy with intravenous meropenem

Cevap

Monotherapy with intravenous meropenem
The patient has an Escherichia coli bloodstream infection with a classic resistance pattern for an Extended-Spectrum Beta-Lactamase (ESBL) producer, evidenced by resistance to ampicillin and advanced-generation cephalosporins (ceftriaxone, cefepime). For ESBL bacteremia, carbapenems (such as meropenem, imipenem, or ertapenem) are the definitive drug of choice. Although piperacillin-tazobactam frequently tests as susceptible in vitro (due to the tazobactam component inhibiting the ESBL enzyme), robust randomized controlled data (such as the MERINO trial) have clearly demonstrated that definitive therapy with piperacillin-tazobactam results in significantly higher 30-day mortality and clinical failure compared to carbapenems in bloodstream infections. Therefore, despite the patient's initial clinical improvement on empiric therapy, the regimen must be escalated to a carbapenem to ensure definitive cure.

Adım Adım Çözüm

1
Analyze the antimicrobial susceptibility report.
Identify resistance to 3rd-generation cephalosporins (ceftriaxone) but susceptibility to carbapenems, indicative of an Extended-Spectrum Beta-Lactamase (ESBL) producing E. coli.
Correct identification of the specific resistance mechanism is mandatory to evaluate true in vivo efficacy versus in vitro testing artifacts.
2
Assess the anatomical site and severity of the infection.
The patient has a confirmed bloodstream infection (bacteremia) originating from the urinary tract.
The efficacy of certain antibiotics varies drastically based on whether the infection is localized (e.g., cystitis) or systemic (e.g., bacteremia).
3
Select the definitive antimicrobial agent.
Transition from empiric piperacillin-tazobactam to a targeted carbapenem (meropenem).
Current IDSA guidelines mandate carbapenems for ESBL bacteremia due to established superiority in mortality outcomes over piperacillin-tazobactam.

Anahtar Kavram

Carbapenems are the definitive treatment of choice for bloodstream infections caused by ESBL-producing organisms; piperacillin-tazobactam should be avoided in bacteremia even if reported as susceptible in vitro.
Soru 287Soru →

A 3535-year-old man who recently emigrated from a country with high tuberculosis endemicity presents to the emergency department. He reports a 66-week history of a persistent, blood-tinged cough, subjective fevers, drenching night sweats, and a 66-kg (1313-lb) weight loss. While in the crowded triage area, he is actively coughing. His vital signs show a temperature of 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}). Arrange the following steps in the most appropriate chronological order for the optimal management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of actions is to first establish airborne infection isolation, followed by initial diagnostic imaging with a chest radiograph, then obtaining definitive microbiological sputum samples, and finally initiating multidrug antituberculous therapy.
The management of suspected active pulmonary tuberculosis follows a strict chronological progression prioritizing public health, then diagnosis, then treatment. The immediate placement of a surgical mask and transfer to an airborne infection isolation room prevents nosocomial transmission. Once isolated, a chest radiograph serves as the initial diagnostic step to quickly evaluate for typical cavitary or infiltrative disease. Following this, consecutive sputum samples for AFB smear and culture must be obtained to confirm the diagnosis and secure isolates for susceptibility testing. Finally, a four-drug treatment regimen is initiated only after all diagnostic samples are successfully collected.

Adım Adım Çözüm

1
Prioritize infection control by placing a mask on the patient and moving them to a negative-pressure isolation room.
Prevents the aerosolized spread of Mycobacterium tuberculosis to other patients and healthcare staff.
Airborne transmission risk is highest when an untreated patient is actively coughing in a shared space.
2
Perform initial diagnostic imaging with a chest radiograph.
Evaluates for classic signs of primary or reactivation tuberculosis, such as upper lobe infiltrates or cavitary lesions.
Provides rapid supportive evidence for the clinical suspicion before waiting for lengthy laboratory tests.
3
Collect 33 consecutive sputum samples for AFB smear and culture.
Secures the biological samples needed for definitive microbiological diagnosis and eventual drug susceptibility testing.
Samples must be collected prior to initiating antibiotics to ensure the highest diagnostic yield.
4
Initiate a four-drug empiric therapy regimen.
Begins the lengthy process of eradicating the mycobacterial infection.
Pharmacotherapy is the definitive treatment but should only be started after isolation and appropriate diagnostic sampling.

Anahtar Kavram

In patients with suspected active pulmonary tuberculosis, strict airborne infection control (masking and negative-pressure isolation) is the absolute first step in management, preceding all diagnostic testing and therapeutic interventions.
Tahmini Süre:45s
Soru 288Soru →

A 71-year-old man is evaluated in the intensive care unit regarding his antimicrobial regimen. He was admitted 12 days ago for acute respiratory distress syndrome secondary to a severe viral pneumonitis and required endotracheal intubation. Five days ago, his clinical status deteriorated with the development of a fever up to 39.4°C (102.9°F), worsening hypoxia, and thick, purulent endotracheal secretions. A chest radiograph at that time demonstrated a new dense consolidation in the left lower lobe. Empiric intravenous therapy with piperacillin-tazobactam, tobramycin, and vancomycin was initiated.

Today, the patient is clinically improving; he is afebrile (37.1°C [98.8°F]), and his ventilator settings have been significantly weaned. The quantitative bronchoalveolar lavage culture obtained five days ago exhibits heavy growth (10510^5 CFU/mL) of *Pseudomonas aeruginosa*. Antimicrobial susceptibility testing indicates the organism is susceptible to piperacillin-tazobactam, cefepime, and ciprofloxacin, but resistant to tobramycin. No other organisms, including methicillin-resistant *Staphylococcus aureus* (MRSA), have been isolated. Blood cultures show no growth.

Which of the following is the most appropriate next step in this patient's pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Discontinue tobramycin and vancomycin, and continue piperacillin-tazobactam monotherapy

Cevap

Discontinue tobramycin and vancomycin, and continue piperacillin-tazobactam monotherapy.
The correct approach for this patient is to discontinue both tobramycin and vancomycin, continuing only piperacillin-tazobactam. The fundamental principle of antimicrobial stewardship in ventilator-associated pneumonia (VAP) is to initiate broad empiric therapy but de-escalate as soon as culture and susceptibility data are available. Because quantitative cultures did not yield MRSA, vancomycin must be stopped to reduce nephrotoxicity risk. Although empiric dual coverage for *Pseudomonas aeruginosa* (e.g., a beta-lactam plus an aminoglycoside) is appropriate to ensure initial activity against potentially resistant isolates, definitive therapy should be narrowed to a single active beta-lactam once susceptibilities are confirmed, provided the patient is not in septic shock. Piperacillin-tazobactam alone is fully active against this isolate and is sufficient for definitive cure.

Adım Adım Çözüm

1
Evaluate the need for continued methicillin-resistant Staphylococcus aureus (MRSA) coverage.
The respiratory cultures did not grow MRSA.
Empiric MRSA coverage (vancomycin) should be discontinued if cultures are negative, in accordance with antimicrobial stewardship principles.
2
Assess the requirement for dual anti-pseudomonal therapy.
The patient's isolate is susceptible to piperacillin-tazobactam, and he is clinically improving.
Dual therapy is recommended for empiric coverage of suspected Pseudomonas infection to increase the likelihood of administering at least one active agent. Once susceptibilities are confirmed, definitive therapy with a single active beta-lactam is indicated.
3
Select the appropriate definitive regimen.
Discontinue tobramycin and vancomycin, retaining piperacillin-tazobactam.
Piperacillin-tazobactam provides adequate targeted monotherapy against this susceptible isolate while minimizing toxicity and resistance pressure.

Anahtar Kavram

In the management of ventilator-associated pneumonia, once pathogen susceptibilities are identified and the patient shows clinical improvement, empiric broad-spectrum therapy should be de-escalated. This includes stopping MRSA coverage if no MRSA is isolated and narrowing dual anti-pseudomonal therapy to a single active beta-lactam agent.
Soru 289Soru →

Match each clinical presentation with the most appropriate first-line targeted or empiric antimicrobial therapy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 24-year-old camper in North Carolina develops fever, severe myalgias, headache, and a petechial rash originating on the wrists and ankles.
A 32-year-old intravenous drug user presents with high fever, a new tricuspid regurgitation murmur, and scattered cavitary lung lesions on chest imaging.
A 19-year-old college dormitory resident presents with sudden fever, nuchal rigidity, and a rapidly spreading purpuric rash on the lower extremities.
A 55-year-old farmer from Ohio presents with chronic cough, low-grade fever, and well-circumscribed verrucous skin lesions; microscopy shows broad-based budding yeast.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The camper with wrist/ankle rash requires oral doxycycline (RMSF); the IV drug user with right-sided endocarditis requires intravenous vancomycin (MRSA); the college student with purpuric meningitis requires intravenous ceftriaxone (Meningococcus); and the farmer with broad-based budding yeast requires oral itraconazole (Blastomycosis).
Each pathogen or clinical syndrome has a highly specific first-line antimicrobial agent guided by local epidemiology, resistance patterns, and pharmacokinetics (such as CNS penetration for meningitis or intracellular activity for rickettsial disease).

Adım Adım Çözüm

1
Analyze the tick-borne disease vignette.
Identify Rocky Mountain Spotted Fever based on the North Carolina location and centripetal petechial rash starting on extremities.
Recognizing the classic triad of fever, headache, and distal rash points directly to Rickettsia rickettsii, which must be treated with doxycycline.
2
Analyze the infective endocarditis vignette.
Identify right-sided (tricuspid) endocarditis complicated by septic pulmonary emboli in an intravenous drug user.
Staphylococcus aureus is the most common pathogen in this demographic, necessitating robust empiric MRSA coverage with vancomycin.
3
Analyze the central nervous system infection vignette.
Identify meningococcal meningitis based on the demographic (dormitory resident) and characteristic purpuric rash.
Neisseria meningitidis is a leading cause of bacterial meningitis in this age group and requires a third-generation cephalosporin like ceftriaxone for optimal CNS penetration and coverage.
4
Analyze the systemic fungal infection vignette.
Identify Blastomyces dermatitidis based on geography (Ohio), verrucous skin lesions, and broad-based budding yeast morphology.
Matching the morphologic description to the pathogen determines the choice of an azole antifungal, specifically itraconazole, for non-life-threatening systemic disease.

Anahtar Kavram

Selection of optimal empiric or targeted antimicrobial therapy based on clinical presentation, epidemiologic risk factors, and microbiological clues.
Soru 290Soru →

A 3232-year-old man comes to the clinic to establish care after recently testing positive for human immunodeficiency virus (HIV). He is currently asymptomatic and has no history of opportunistic infections. Vital signs are within normal limits. Physical examination reveals no lymphadenopathy, oral thrush, or skin lesions. Laboratory evaluation shows a CD4 T-lymphocyte count of 38/μL38/\mu\text{L} and an HIV RNA viral load of 280,000280,000 copies/mL. Serologic testing is positive for *Toxoplasma gondii* IgG antibodies. An interferon-gamma release assay is negative. An antiretroviral therapy (ART) regimen consisting of bictegravir, emtricitabine, and tenofovir alafenamide is initiated today. In addition to ART, which of the following is the most appropriate prophylactic antimicrobial regimen for this patient?

Cevabı ve açıklamayı göster

Cevap: Trimethoprim-sulfamethoxazole only

Cevap

Trimethoprim-sulfamethoxazole only
The correct answer provides targeted prophylaxis for the exact pathogens this patient is at risk for without inappropriately prescribing unneeded antimicrobials. A CD4 count <200/μL< 200/\mu\text{L} necessitates prophylaxis against *Pneumocystis jirovecii* pneumonia, and a count <100/μL< 100/\mu\text{L} combined with positive IgG antibodies requires prophylaxis against *Toxoplasma gondii*. Trimethoprim-sulfamethoxazole provides highly effective coverage for both. Although the CD4 count is <50/μL< 50/\mu\text{L}, primary prophylaxis for *Mycobacterium avium* complex (MAC) is no longer recommended for patients who are immediately starting antiretroviral therapy.

Adım Adım Çözüm

1
Analyze the patient's CD4 count and serologic status.
The CD4 count is 38/μL38/\mu\text{L} (which is <200/μL< 200/\mu\text{L} and <100/μL< 100/\mu\text{L}) and Toxoplasma IgG is positive.
To identify which opportunistic pathogens the patient is currently at high risk for acquiring.
2
Identify the required primary prophylaxis regimens.
Prophylaxis is urgently required for Pneumocystis jirovecii (CD4 <200/μL< 200/\mu\text{L}) and Toxoplasma gondii (CD4 <100/μL< 100/\mu\text{L} with positive IgG). Trimethoprim-sulfamethoxazole effectively covers both.
To select the appropriate evidence-based antimicrobial agent.
3
Determine if Mycobacterium avium complex (MAC) prophylaxis is needed.
MAC prophylaxis (such as azithromycin) is not indicated because the patient is initiating fully suppressive antiretroviral therapy (ART) today.
Contemporary guidelines have removed the recommendation for MAC prophylaxis in patients starting ART, even when the CD4 count is <50/μL< 50/\mu\text{L}.

Anahtar Kavram

In patients with HIV, primary prophylaxis for Mycobacterium avium complex (MAC) is no longer recommended if antiretroviral therapy is initiated immediately, but prophylaxis for Pneumocystis jirovecii and Toxoplasma gondii is still required based on CD4 thresholds.
Soru 291Soru →

For each clinical presentation described below, select the most appropriate initial antimicrobial agent according to current guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Erythema migrans rash following a tick bite in an endemic region
Painful, grouped vesicles on an erythematous base in a unilateral dermatomal distribution
Exudative pharyngitis, fever, and anterior cervical lymphadenopathy with a positive rapid streptococcal antigen test
Purulent urethral discharge with a nucleic acid amplification test positive for Neisseria gonorrhoeae

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations correspond to Lyme disease (Doxycycline), Herpes zoster (Valacyclovir), Group A Streptococcal pharyngitis (Penicillin V), and Gonococcal urethritis (Ceftriaxone).
Each match correctly pairs a classic infectious disease syndrome with its universally accepted standard-of-care antimicrobial therapy.

Adım Adım Çözüm

1
Identify the primary diagnosis for each specific clinical presentation.
The diagnoses are early localized Lyme disease, herpes zoster, streptococcal pharyngitis, and gonorrhea.
Accurate clinical and laboratory diagnosis is required to select the appropriate pathogen-directed therapy.
2
Determine the guideline-recommended first-line antimicrobial for each established diagnosis.
Lyme disease requires doxycycline; herpes zoster requires valacyclovir; streptococcal pharyngitis requires penicillin V; gonorrhea requires ceftriaxone.
First-line agents maximize clinical efficacy while minimizing antimicrobial resistance and side effects.

Anahtar Kavram

First-line antimicrobial therapy for common outpatient infectious diseases
Soru 292Soru →

An otherwise healthy 42-year-old male is evaluated in the ambulatory care center due to a painful swelling on his right thigh. The lesion has been progressively enlarging over the past three days. He takes no medications and has no significant past medical history. Vital signs demonstrate a temperature of 37.1°C (98.8°F), blood pressure of 122/78 mm Hg, and a heart rate of 74/min. Physical examination of the right anterior thigh reveals a 3-cm, highly tender, fluctuant, erythematous nodule with a central purulent punctum. There is no significant surrounding induration, and no regional lymphadenopathy is appreciated. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Incision and drainage only

Cevap

Incision and drainage only
The correct approach is incision and drainage only. The patient presents with a simple, uncomplicated cutaneous abscess, characterized by a fluctuant, tender nodule with a purulent center. In an otherwise healthy, immunocompetent patient with a single small abscess (typically <5 cm), no systemic signs of infection (such as fever or tachycardia), and minimal surrounding cellulitis, the definitive treatment is mechanical source control. Incision and drainage alone provides excellent cure rates. Systemic antibiotics are not indicated in this scenario.

Adım Adım Çözüm

1
Evaluate the clinical presentation to determine the type and severity of the infection.
The patient has a localized, 3-cm fluctuant mass with a purulent punctum and normal vital signs, indicating a simple, uncomplicated cutaneous abscess.
Categorizing the infection is necessary to determine if both source control and systemic antibiotics are required.
2
Apply current treatment guidelines for an uncomplicated cutaneous abscess.
The standard of care for a single, small abscess in an immunocompetent patient without systemic symptoms is mechanical drainage.
Source control is the most critical intervention for purulent collections.
3
Determine if adjunctive antibiotics are indicated.
Adjunctive antibiotics are unnecessary as the patient lacks high-risk features (e.g., severe extensive surrounding cellulitis, systemic inflammatory response syndrome, immunocompromise).
Prescribing antibiotics when not indicated violates principles of antimicrobial stewardship.

Anahtar Kavram

Management of uncomplicated cutaneous abscesses
Soru 293Soru →

A 6262-year-old man with poorly controlled type 2 diabetes mellitus is admitted to the hospital with a non-healing ulcer on the plantar aspect of his right foot. The ulcer is surrounded by 44 cm of erythema and warmth. During physical examination, a sterile metal probe easily reaches the underlying bone. His temperature is 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), blood pressure is 130/80130/80 mm Hg, and pulse is 9696/min. Laboratory studies show a leukocyte count of 14,500/mm314,500/\text{mm}^3. He is started on empiric intravenous vancomycin and piperacillin-tazobactam. A bone biopsy is performed on the second day of admission. By day 55, his fever has resolved, and the erythema has significantly decreased. The bone biopsy cultures grow only Staphylococcus aureus, which is sensitive to oxacillin, cefazolin, and clindamycin, but resistant to penicillin. No Gram-negative bacilli or anaerobes are isolated. Which of the following is the most appropriate next step in pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Discontinue the current regimen and begin intravenous cefazolin

Cevap

Discontinue the current broad-spectrum regimen and begin intravenous cefazolin to specifically target Methicillin-Susceptible Staphylococcus aureus (MSSA).
The correct answer is to discontinue the broad-spectrum regimen and begin intravenous cefazolin. This patient presented with a diabetic foot infection complicated by osteomyelitis, which appropriately prompted empiric therapy with vancomycin and piperacillin-tazobactam. The gold standard for diagnosing the causative organism in osteomyelitis is a bone biopsy. The culture unequivocally identified Methicillin-Susceptible Staphylococcus aureus (MSSA) as the sole pathogen, with no Gram-negative or anaerobic organisms isolated. According to the core principles of antimicrobial stewardship, therapy must be de-escalated to the most narrow-spectrum, effective agent once culture and susceptibility data are available. Intravenous cefazolin (or an anti-staphylococcal penicillin such as nafcillin) is the treatment of choice for MSSA osteomyelitis because it is highly efficacious, narrow-spectrum, and avoids the selective pressure for multi-drug resistant organisms.

Adım Adım Çözüm

1
Identify the primary diagnosis and clinical scenario.
The patient has a diabetic foot ulcer with underlying osteomyelitis (indicated by a positive probe-to-bone test), initially appropriately treated with empiric broad-spectrum antibiotics.
To establish the baseline clinical state and the original indication for broad-spectrum therapy.
2
Interpret the definitive diagnostic data.
Bone biopsy culture at day 5 shows exclusively Staphylococcus aureus that is sensitive to oxacillin, confirming it is Methicillin-Susceptible S. aureus (MSSA).
Bone biopsy is the gold standard for defining the microbiology of osteomyelitis, superseding the initial assumption of a polymicrobial infection.
3
Apply principles of antimicrobial stewardship.
The empiric broad-spectrum coverage (vancomycin and piperacillin-tazobactam) must be de-escalated to target only MSSA.
To prevent antibiotic resistance, reduce toxicity, and provide the most efficacious targeted therapy for the specific pathogen isolated.
4
Select the optimal definitive pharmacotherapy.
Intravenous cefazolin is chosen.
Cefazolin is a first-generation cephalosporin and the drug of choice for severe MSSA infections, providing narrow-spectrum, highly bactericidal activity.

Anahtar Kavram

Antimicrobial stewardship dictates the de-escalation of empiric broad-spectrum antibiotics to targeted, narrow-spectrum therapy based on definitive culture results; intravenous cefazolin (or an anti-staphylococcal penicillin) is the treatment of choice for MSSA osteomyelitis.
Soru 294Soru →

Match each clinical vignette describing an immunocompromised patient with an infectious disease to the most appropriate targeted antimicrobial therapy, taking into account patient-specific contraindications.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 4545-year-old man with acute myeloid leukemia and profound neutropenia develops fever, pleuritic chest pain, and hemoptysis. Chest CT shows a dense consolidation with a halo sign. Serum galactomannan is markedly elevated. Baseline ECG reveals a QTc interval of 560560 msec.
A 3838-year-old man with untreated HIV presents with severe hypoxemia (PaO2PaO_2 5555 mmHg on room air) and bilateral interstitial infiltrates. Induced sputum is positive for Pneumocystis jirovecii. He has a known history of severe glucose-6-phosphate dehydrogenase (G6PD) deficiency.
A 6565-year-old woman with recurrent UTIs presents with septic shock. Blood cultures grow Extended-Spectrum Beta-Lactamase (ESBL)-producing Escherichia coli resistant to fluoroquinolones. She has a documented history of IgE-mediated anaphylaxis to all penicillins, cephalosporins, and carbapenems.
A 5050-year-old renal transplant recipient presents with decreased visual acuity. Fundoscopy reveals perivascular retinal exudates with hemorrhage. Complete blood count shows a leukocyte count of 1,200/mm31,200/\text{mm}^3 and absolute neutrophil count of 400/mm3400/\text{mm}^3.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Each scenario requires bypassing the standard first-line antimicrobial agent due to a critical, patient-specific contraindication: use isavuconazole to avoid QTc prolongation in aspergillosis, pentamidine to avoid hemolysis in G6PD-deficient severe PCP, amikacin to avoid beta-lactam anaphylaxis in ESBL bacteremia, and foscarnet to avoid worsening neutropenia in CMV retinitis.
Correct matching relies on synthesizing the infectious diagnosis with critical pharmacological contraindications to select the single best alternative therapy.

Adım Adım Çözüm

1
Evaluate the first vignette for diagnosis and contraindications.
Diagnosis: Invasive Aspergillosis. Contraindication: QTc 560 msec.
Voriconazole is standard but prolongs QTc. Isavuconazole must be selected because it uniquely shortens the QTc interval.
2
Evaluate the second vignette for severity, diagnosis, and contraindications.
Diagnosis: Severe Pneumocystis jirovecii pneumonia (PaO2 < 70 mmHg requires steroids). Contraindication: G6PD deficiency.
TMP-SMX, Dapsone, and Primaquine induce oxidative stress and hemolysis in G6PD deficiency. IV pentamidine is required for severe disease.
3
Evaluate the third vignette for resistance patterns and allergies.
Diagnosis: ESBL E. coli bacteremia. Contraindication: Anaphylaxis to all beta-lactams.
Carbapenems are standard for ESBL, but the anaphylaxis history precludes their use. Aminoglycosides (Amikacin) offer non-beta-lactam bactericidal coverage.
4
Evaluate the fourth vignette for viral etiology and drug toxicities.
Diagnosis: CMV retinitis. Contraindication: Pre-existing severe neutropenia (ANC 400).
Ganciclovir causes dose-dependent bone marrow suppression. Foscarnet treats CMV effectively while avoiding further myelosuppression.

Anahtar Kavram

Antimicrobial Stewardship and High-Yield Drug Contraindications
Tahmini Süre:3m 0s
Soru 295Soru →

A 62-year-old man is brought to the emergency department by his husband due to a 24-hour history of severe headache, high fever, and progressive confusion. He has a history of end-stage renal disease and underwent a deceased-donor renal transplantation 3 years ago. His current medications include tacrolimus, mycophenolate mofetil, and prednisone. His temperature is 39.2°C (102.6°F), blood pressure is 112/74 mmHg, pulse is 115/min, and respirations are 20/min. Physical examination reveals marked nuchal rigidity and lethargy. He is oriented to person only, but there are no focal neurologic deficits.

Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for the optimal management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first obtain blood cultures, immediately administer empiric antibiotics and dexamethasone, perform a head CT scan, perform a lumbar puncture, and finally narrow antimicrobial therapy based on results.
The most appropriate sequence of steps for this patient is obtaining blood cultures, administering empiric antibiotics and dexamethasone, performing a head CT, performing a lumbar puncture, and finally narrowing therapy based on results. This patient presents with suspected bacterial meningitis. Given his immunocompromised state (renal transplant) and altered mental status (confusion, lethargy), he has clear indications for a non-contrast head CT prior to a lumbar puncture (LP) to rule out a focal mass lesion and prevent brain herniation. Because the LP will be delayed by the CT scan, empiric antibiotics MUST be administered immediately. However, to maximize the chance of identifying the causative organism, two sets of blood cultures should be drawn just before the antibiotics are given. The empiric regimen includes dexamethasone, ceftriaxone, vancomycin, and ampicillin (for Listeria coverage). Once the CT scan clears the patient, the LP can be safely performed. Finally, therapy is targeted based on CSF culture and susceptibility results to practice sound antimicrobial stewardship.

Adım Adım Çözüm

1
Identify the clinical syndrome and indications for neuroimaging.
The patient has signs of acute bacterial meningitis along with altered mental status and an immunocompromised state.
These findings are specific indications for obtaining a head CT before performing a lumbar puncture (LP) to avoid the risk of brain herniation.
2
Sequence the diagnostic and therapeutic interventions appropriately.
Blood cultures must be drawn first, followed immediately by empiric antimicrobial therapy, then head CT, and finally LP.
Delaying antibiotics for a head CT or LP significantly increases mortality. However, blood cultures must be drawn just before antibiotics to ensure the pathogen can be identified.
3
Select the appropriate empiric regimen.
Dexamethasone, ceftriaxone, vancomycin, and ampicillin are administered.
This broad-spectrum regimen covers Streptococcus pneumoniae, Neisseria meningitidis, Listeria monocytogenes (ampicillin is necessary due to his age and immunocompromised state), and resistant organisms.
4
Determine the final step in management.
Narrow antimicrobial therapy based on CSF analysis.
Once the specific pathogen and its susceptibilities are identified from the CSF, de-escalating antibiotics promotes antimicrobial stewardship and minimizes toxicity.

Anahtar Kavram

In patients with suspected bacterial meningitis who have indications for a head CT prior to lumbar puncture (e.g., immunocompromised state, altered mental status), empiric antibiotics and blood cultures must NOT be delayed while waiting for neuroimaging.
Soru 296Soru →

A 24-year-old man presents to the clinic complaining of a diffuse, nonpruritic maculopapular rash that involves his palms and soles, accompanied by mild malaise and generalized lymphadenopathy. He reports unprotected sexual contact with a new partner approximately ten weeks ago. You suspect a systemic sexually transmitted infection. Arrange the following steps in the most appropriate chronological order for the diagnostic evaluation, treatment, and ongoing management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological order is: Initial serologic screening test, followed by a complementary confirmatory serologic test, then administration of intramuscular benzathine penicillin G, and finally repeating quantitative nontreponemal testing at 6 and 12 months.
The proper clinical management of syphilis follows a strict protocol. First, an initial screening test (nontreponemal or treponemal depending on the local algorithm) is ordered. Because no single test is perfectly sensitive and specific, a positive screen must be followed by a confirmatory test using a different methodology to avoid treating false positives. Once the diagnosis of secondary syphilis is secure, the patient is treated with intramuscular benzathine penicillin G. Finally, because Treponema pallidum cannot be cultured, disease eradication is confirmed by monitoring quantitative nontreponemal titers (such as RPR) at 6 and 12 months, looking for a four-fold decrease.

Adım Adım Çözüm

1
Perform an initial serologic screening test.
Identifies antibodies that may indicate a syphilis infection.
Both the traditional and reverse-sequence testing algorithms require a highly sensitive initial screen to capture all potential cases.
2
Perform a complementary confirmatory serologic test.
Establishes a definitive diagnosis of secondary syphilis.
Initial tests (especially nontreponemal tests like RPR) can be falsely positive due to autoimmune diseases, pregnancy, or other infections. A second test using a different methodology is mandatory to confirm the diagnosis.
3
Administer a single dose of intramuscular benzathine penicillin G.
Eradicates the active Treponema pallidum infection.
This is the definitive, curative treatment for early (primary, secondary, and early latent) syphilis.
4
Repeat quantitative nontreponemal serologic testing at 6 and 12 months.
Confirms therapeutic success and resolution of the disease.
A four-fold decline in nontreponemal titers indicates adequate treatment response. Treponemal tests cannot be used for this step as they usually remain positive for life.

Anahtar Kavram

The standard workflow for managing secondary syphilis involves two-step serologic diagnostic testing, immediate treatment with intramuscular penicillin upon confirmation, and long-term serologic monitoring to ensure cure.
Soru 297Soru →

A 65-year-old woman is hospitalized due to a 2-day history of high fever, right-sided flank pain, and altered mental status. She has a history of poorly controlled type 2 diabetes mellitus and recurrent urinary tract infections. On admission, her temperature is 39.2°C (102.6°F), blood pressure is 88/56 mm Hg, pulse is 118/min, and respirations are 22/min. Physical examination is notable for severe right costovertebral angle tenderness. Laboratory studies show a leukocyte count of 18,500/mm³. Urinalysis is positive for leukocyte esterase, nitrites, and numerous leukocytes. Blood and urine cultures are obtained, and the patient is started on empiric intravenous piperacillin-tazobactam. Over the next 48 hours, her fever resolves, and her hemodynamics normalize.

Preliminary results from both blood and urine cultures grow *Enterobacter cloacae*. Antimicrobial susceptibility testing reveals the isolate is susceptible to ceftriaxone, cefepime, piperacillin-tazobactam, meropenem, and gentamicin. It is resistant to ciprofloxacin and trimethoprim-sulfamethoxazole. Which of the following is the most appropriate next step in antimicrobial therapy?

Cevabı ve açıklamayı göster

Cevap: Switch to intravenous cefepime

Cevap

The most appropriate step is to switch the patient's therapy to intravenous cefepime.
The correct approach for treating invasive infections (e.g., bacteremia) caused by organisms with a high risk of clinically significant AmpC beta-lactamase production (such as *Enterobacter cloacae*, *Klebsiella aerogenes*, and *Citrobacter freundii*) is to use a fourth-generation cephalosporin, such as cefepime. Cefepime is highly stable against AmpC hydrolysis and is a weak inducer of the enzyme. Although carbapenems (like meropenem) are also highly effective, antimicrobial stewardship guidelines strongly recommend cefepime as a carbapenem-sparing targeted therapy for susceptible AmpC isolates.

Adım Adım Çözüm

1
Identify the pathogen and its specific intrinsic resistance mechanisms.
The pathogen is *Enterobacter cloacae*, a classic organism known to harbor an inducible chromosomal AmpC beta-lactamase gene.
Recognizing the intrinsic resistance mechanisms of specific organisms is essential for safely interpreting laboratory susceptibility reports.
2
Interpret the susceptibility results in the context of the pathogen's AmpC production risk.
Although ceftriaxone and piperacillin-tazobactam show in vitro susceptibility, third-generation cephalosporins are strong inducers of AmpC and can lead to rapid hyperproduction and clinical failure in vivo.
In vitro susceptibility does not always guarantee in vivo clinical success, particularly with inducible beta-lactamase producers.
3
Select the optimal targeted therapy by balancing clinical efficacy and antimicrobial stewardship.
Cefepime, a fourth-generation cephalosporin, is highly stable against AmpC hydrolysis and is a weak inducer, making it the drug of choice. Meropenem is effective but should be reserved for cases where cefepime cannot be used.
Cefepime provides definitive, targeted therapy for invasive AmpC infections while adhering to stewardship principles by sparing overly broad-spectrum agents like carbapenems.

Anahtar Kavram

Management of invasive infections caused by moderate-to-high risk AmpC beta-lactamase-producing organisms (e.g., *Enterobacter cloacae*) requires avoiding third-generation cephalosporins despite in vitro susceptibility; cefepime is the preferred definitive therapy.
Soru 298Soru →

A 36-year-old man with a history of advanced, untreated HIV infection (CD4 count 28 cells/mm328 \text{ cells/mm}^3) is brought to the emergency department due to progressive confusion, severe headaches, and left-sided weakness over the past week. His temperature is 38.1∘C38.1^\circ\text{C} (100.6∘F100.6^\circ\text{F}). Neurologic examination reveals a dense left hemiparesis. MRI of the brain reveals multiple 1- to 2-cm ring-enhancing lesions in the right basal ganglia and frontal lobe with marked surrounding vasogenic edema causing a 4-mm midline shift. Serum *Toxoplasma gondii* IgG antibodies are positive.

Arrange the following clinical actions in the correct chronological sequence according to the standard management algorithm for this patient, assuming a complete lack of clinical or radiographic response to the first-line medical intervention.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first start empiric toxoplasmosis therapy, follow up with a repeat brain MRI in 10-14 days to check for response, perform a stereotactic brain biopsy when there is no improvement, test the tissue for EBV DNA to confirm lymphoma, and finally initiate high-dose methotrexate therapy.
In patients with advanced HIV (CD4 < 100 cells/mm³) presenting with multiple ring-enhancing brain lesions and positive Toxoplasma serology, the standard of care is to initiate an empiric trial of anti-Toxoplasma therapy (pyrimethamine, sulfadiazine, and leucovorin). Because these lesions frequently cause marked vasogenic edema and mass effect, early lumbar puncture is contraindicated due to the risk of cerebral herniation. The clinical and radiographic response to this empiric trial is assessed via repeat MRI in 10 to 14 days. If the lesions do not regress or if the patient worsens, the diagnosis of Toxoplasma encephalitis becomes highly unlikely. At this juncture, primary central nervous system lymphoma (PCNSL)—the second most common cause of ring-enhancing lesions in HIV—becomes the primary differential diagnosis. A stereotactic brain biopsy is then indicated to establish a definitive tissue diagnosis. In HIV patients, PCNSL is almost universally an AIDS-defining malignancy driven by Epstein-Barr virus (EBV), which can be identified in the biopsied tissue via PCR or in-situ hybridization. Upon confirmation of PCNSL, the first-line targeted treatment is systemic chemotherapy utilizing high-dose methotrexate.

Adım Adım Çözüm

1
Evaluate the patient's initial presentation and infectious risk profile.
The patient has advanced HIV, multiple ring-enhancing lesions, and positive Toxo serology, pointing to Toxoplasma encephalitis.
Toxoplasmosis is the most common cause of focal brain lesions in HIV patients with CD4 < 100 cells/mm³.
2
Determine the first therapeutic intervention.
Initiate empiric pyrimethamine, sulfadiazine, and leucovorin.
Immediate medical treatment is required. Brain biopsy and lumbar puncture are deferred initially due to the high probability of toxoplasmosis and contraindications (mass effect risk for herniation).
3
Establish the follow-up interval for the empiric trial.
Perform a repeat brain MRI in 10 to 14 days.
To determine if the empiric trial is successful. A complete lack of clinical or radiographic response strongly indicates an alternative diagnosis.
4
Identify the next procedural step for treatment failure.
Consult neurosurgery for a stereotactic brain biopsy.
Failure of empiric therapy shifts the most likely diagnosis to Primary Central Nervous System Lymphoma (PCNSL), which requires definitive tissue confirmation before starting chemotherapy.
5
Confirm the alternative diagnosis pathologically.
Send biopsied tissue for EBV DNA testing.
PCNSL in immunocompromised patients is almost universally driven by Epstein-Barr virus (EBV).
6
Select the targeted therapy for the confirmed diagnosis.
Initiate high-dose methotrexate.
This is the first-line systemic chemotherapy standard of care for Primary CNS Lymphoma.

Anahtar Kavram

Algorithm for differentiating and managing Toxoplasma encephalitis versus Primary Central Nervous System Lymphoma in patients with advanced HIV.
Soru 299Soru →

A hospital's antimicrobial stewardship and infectious diseases teams are reviewing several complex cases involving severe adverse drug events. Match each patient's clinical presentation of an antimicrobial-induced complication to the specific pharmacologic agent most likely responsible.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 54-year-old man receiving intravenous therapy for right-sided methicillin-resistant Staphylococcus aureus (MRSA) endocarditis develops new-onset fever, hypoxic respiratory failure, and diffuse pulmonary infiltrates with peripheral eosinophilia.
A 36-year-old woman treated with oral therapy for a polymicrobial diabetic foot infection presents to the emergency department with severe, sudden-onset posterior ankle pain and swelling that worsened after walking.
A 45-year-old man receiving high-dose prophylaxis for Pneumocystis jirovecii is noted to have asymptomatic hyperkalemia and an elevation in serum creatinine, though his true glomerular filtration rate remains unchanged.
A 68-year-old woman on long-term oral therapy for vancomycin-resistant Enterococcus (VRE) osteomyelitis develops bilateral stocking-glove sensory loss, visual changes, and new-onset thrombocytopenia.
A 72-year-old man with chronic kidney disease receiving intravenous therapy for Pseudomonas aeruginosa pneumonia develops sudden myoclonus, encephalopathy, and non-convulsive status epilepticus.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Eosinophilic pneumonia matches with Daptomycin. Achilles tendinopathy matches with Levofloxacin. Hyperkalemia and pseudo-kidney injury match with Trimethoprim-sulfamethoxazole. Myelosuppression and neuropathy match with Linezolid. Neurotoxicity and seizures match with Cefepime.
Each clinical vignette describes a hallmark adverse reaction to a specific antimicrobial agent used in serious infections. Daptomycin is known to cause acute eosinophilic pneumonia. Levofloxacin carries a black box warning for Achilles tendinopathy. Trimethoprim-sulfamethoxazole blocks ENaC channels causing hyperkalemia and inhibits creatinine secretion without true renal injury. Linezolid causes mitochondrial toxicity leading to cytopenias and neuropathy after prolonged use. Cefepime accumulates in renal failure, lowering the seizure threshold and causing distinct encephalopathy.

Adım Adım Çözüm

1
Analyze each clinical vignette to identify the underlying infection and the specific adverse pharmacological event.
Identified toxicities: eosinophilic pneumonia, tendinopathy, hyperkalemia with pseudo-AKI, prolonged-use mitochondrial toxicity, and neurotoxicity.
Accurate identification of the syndrome is required to link it to the offending agent.
2
Correlate the identified toxicities with the antimicrobial agents known to treat the specified infections.
Daptomycin causes eosinophilic pneumonia; Levofloxacin causes tendinopathy; TMP-SMX alters potassium and creatinine handling; Linezolid causes neuropathy and cytopenias; Cefepime causes neurotoxicity in renal failure.
Antimicrobial stewardship requires monitoring for highly specific, high-yield adverse effects associated with targeted therapies.
3
Pair each clinical presentation with its definitive causative agent based on pharmacodynamic toxicity profiles.
All five distinct clinical scenarios are correctly matched to their respective antimicrobial agents.
Finalizing the matches completes the clinical evaluation.

Anahtar Kavram

Recognizing classic and severe adverse pharmacological effects of commonly used targeted antimicrobial therapies.
Soru 300Soru →

A 28-year-old resident physician sustains a deep percutaneous needlestick injury to her thumb while drawing arterial blood from a patient. The patient has a known history of untreated HIV with a viral load of 250,000 copies/mL. The needle is visibly contaminated with the patient's blood. Arrange the following steps in the most appropriate chronological order for the management of this occupational exposure.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to perform immediate first aid (washing the wound), obtain baseline serological testing, initiate a 3-drug post-exposure prophylaxis regimen, and finally conduct longitudinal follow-up testing.
Occupational exposures to HIV require a standardized, chronological approach to maximize safety and efficacy. Immediate first aid (washing) physically decreases the pathogen load. Administrative reporting and baseline serologies establish the worker's initial status. Because viral integration can occur rapidly, empiric 3-drug antiretroviral post-exposure prophylaxis must be started immediately following baseline testing, without waiting for the lab results. Finally, longitudinal serologic follow-up is necessary because HIV seroconversion can be delayed up to 6 months.

Adım Adım Çözüm

1
Wash the puncture site thoroughly with soap and water.
Viral bioburden at the inoculation site is physically reduced.
First aid is the most immediate, time-sensitive action to minimize systemic entry of the virus.
2
Obtain baseline HIV, hepatitis B, and hepatitis C serologies from the exposed resident.
The resident's pre-exposure serological status is documented.
Baseline testing is essential for occupational health records and ensures PEP is not inadvertently used as inadequate therapy for an unrecognized pre-existing infection.
3
Initiate a 28-day post-exposure prophylaxis regimen with tenofovir, emtricitabine, and raltegravir.
Systemic antiretroviral therapy is established.
To prevent viral replication and integration into the host genome, PEP must be started rapidly (optimally within 2 hours, up to 72 hours).
4
Perform follow-up HIV antibody and antigen testing at 6 weeks, 12 weeks, and 6 months.
Long-term monitoring for seroconversion is completed.
The incubation period for HIV means seroconversion might not be detectable immediately; longitudinal follow-up is necessary to confirm the exposure did not result in infection.

Anahtar Kavram

Management sequence for high-risk occupational HIV exposure
ÖncekiSayfa 15 / 26Sonraki
Infectious Diseases Alıştırma Soruları — USMLE Step 2 CK — Sayfa 15 | Examkin